FDA approves Yuvezzi (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% for presbyopia | Optometry Times - Clinical News

Published on January 29, 2026
Formerly known as Brimochol PF, the dual-agent eye drop is now the first and only of its kind for the treatment of presbyopia in adults.
Continue reading on website
Other news

Eye care sector must show support for glaucoma care bill, Specsavers says

January 29, 2026
Giles Edmonds, Specsavers clinical services director, has emphasised the importance of community optometry’s support after the Glaucoma Care: England Bill was presented to Parliament on 20 January

MRI study links glymphatic system dysfunction to idiopathic intracranial hypertension | Optometry Times - Clinical News

January 29, 2026
This research is part of the IIH Research and Treatment Initiative, a new philanthropy-funded program launched at Mass General Brigham.